<?xml version="1.0" encoding="UTF-8"?>
<p id="par0470">Their results revealed that non-COVID-19 pneumonia was more likely to manifest with air bronchogram (23% compared to 14% for COVID-19), pleural thickening (33 vs. 15%), pleural effusion (39 vs. 4%), central with peripheral distribution (35 vs. 14%), and lymphadenopathy (10,2 vs. 2,7%). While COVID-19 pneumonia was more likely to manifest with GGO (91% vs 68% for non- COVID-19), fine reticular opacity (56% vs 22%), reverse halo sign (11% vs 1%), vascular thickening (59% vs 22%), and bilateral peripheral distribution (80% vs 57%) [
 <xref rid="bib0375" ref-type="bibr">75</xref>].
</p>
